U.S. FDA clears lung cancer IND for CVHNLC, a proprietary off-the-shelf candidate targeting squamous non-small cell lung cancer (sqNCLC), with clinical study expected to begin H2 2025; Clinical Trial ...

In an era that FDA Commissioner Marty Makary, MD, MPH, calls an "epidemic of distrust" toward health institutions, previously ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work ...

Former Visalia doctor Stephen D. Meis pleaded guilty to introducing misbranded drugs into interstate commerce, including a treatment for COVID-19 that was sold to practitioners and public ...

Surgeons in southern California successfully completed the world's first-ever human bladder transplant on 41-year-old Oscar ...

With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...

President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could ...

The vaccine, Nuvaxovid, is the third coronavirus shot to gain full approval, joining vaccines from Pfizer and Moderna. It has ...

The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.